Scedosporium apiospermum fungemia successfully treated with voriconazole and terbinafine
Ra’ed Jabr, Kassem Hammoud
Abstract
Scedosporium apiospermum is ubiquitous in the environment and is considered an emerging infection. Immunocompromised hosts can have a wide spectrum of diseases ranging from cutaneous to disseminated disease that may involve pulmonary, central nervous system, or bone. Disseminated disease in immunocompetent hosts is uncommon. Treatment of deep-seated infections is challenging because of the limited susceptibility of the Scedosporium species to all current antifungal drugs. We report a case of Scedosporidium apiospermum fungemia with a presumed pulmonary involvement in an immunocompetent patient. The fungemia was successfully treated with oral voriconazole and terbinafine.
Topics & Concepts
Scedosporium apiospermumVoriconazoleFungemiaTerbinafineMedicineDermatologyAntifungalItraconazoleAntifungal resistance and susceptibilityFungal Infections and StudiesInfectious Diseases and Mycology